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https://doi.org/10.1016/j.celrep.2021.109317SUMMARYThe R2TP (RUVBL1-RUVBL2-RPAP3-PIH1D1) complex, in collaboration with heat shock protein 90 (HSP90),
functions as a chaperone for the assembly and stability of protein complexes, including RNA polymerases,
small nuclear ribonucleoprotein particles (snRNPs), and phosphatidylinositol 3-kinase (PI3K)-like kinases
(PIKKs) such as TOR and SMG1. PIKK stabilization depends on an additional complex of TELO2, TTI1,
and TTI2 (TTT), whose structure and function are poorly understood. The cryoelectron microscopy (cryo-
EM) structure of the human R2TP-TTT complex, together with biochemical experiments, reveals the mech-
anism of TOR recruitment to the R2TP-TTT chaperone. The HEAT-repeat TTT complex binds the kinase
domain of TOR, without blocking its activity, and delivers TOR to the R2TP chaperone. In addition, TTT reg-
ulates the R2TP chaperone by inhibiting RUVBL1-RUVBL2 ATPase activity and by modulating the conforma-
tion and interactions of the PIH1D1 and RPAP3 components of R2TP. Taken together, our results show how
TTT couples the recruitment of TOR to R2TP with the regulation of this chaperone system.INTRODUCTION
The R2TP complex is a specialized co-chaperone of heat shock
protein 90 (HSP90), consisting of an alternating heterohexameric
ring of two AAA+ ATPases, RUVBL1 (also known as Pontin,
TIP49, and TIP49a, and in yeast as Rvb1p) and RUVBL2 (also
known as Reptin, TIP48, and TIP49b, and in yeast as Rvb2p), a
TPR-domain protein, RPAP3 (Tah1p in yeast), and a PIH-domain
protein, PIH1D1 (Pih1p in yeast) (Martino et al., 2018; Rivera-Cal-
zada et al., 2017). R2TP has been implicated in many biological
processes, including the assembly, activation, and stabilization
of phosphatidylinositol 3 kinase (PI3K)-related kinases (PIKKs)
such as mTORC1, SMG1, ATM, DNA-PK, and ATR/ATRIP, the
assembly of RNA polymerase II and small nucleolar ribonucleo-
protein particles (snoRNPs), and in the assembly of axonemal
dyneins (von Morgen et al., 2015). Most recently, R2TP has
been implicated in the function and assembly of replisome and
nucleocapsids of RNA viruses responsible for measles and
Ebola (Katoh et al., 2019; Morwitzer et al., 2019)
The structures of yeast and human R2TP complexes have
been analyzed by cryoelectron microscopy (cryo-EM) (Martino
et al., 2018; Rivera-Calzada et al., 2017; Tian et al., 2017).
RUVBL1/Rvb1p and RUV/Rvb2p (henceforth R2) form a hetero-This is an open access article undhexamer through interaction of the alternating AAA domains of
each subunit. Domain II (DII) from each subunit projects from
the hexameric ring and defines the DII face of R2, while the
AAA-ATPase domains define the opposing AAA face. In all R2
complexes studied so far, other associated proteins predomi-
nantly bind to the DII face of the ring, and in yeast and human
R2TP complexes, the HSP90-recruiting TPR domains of
RPAP3/Tah1p and the client-recruiting PIH-domain-containing
RPAP3/Tah1p-PIH1D1/Pih1p complex (henceforth TP), are
located on this face of the ring. In human R2TP, RPAP3, a
much larger protein than the yeast homolog Tah1p, contains a
unique C-terminal a-helical domain that binds to the AAA side
of each RUVBL2 subunit. This RUVBL2-binding domain (RBD)
provides a tight anchor for RPAP3 in complex with PIH1D1, while
allowing for considerable flexibility of the TPR andN-terminal do-
mains of RPAP3 at the DII face of R2. Since each R2TP complex
contains three copies of RUVBL2, up to three RPAP3-PIH1D1
complexes can bind per R2TP, but although flexibly tethered,
only one PIH1D1 at a time can interact directly to R2. One mole-
cule of PIH1D1 binds to the DII domain of one RUVBL2 subunit,
inducing conformational changes that facilitate nucleotide ex-
change in this subunit and promote ATP turnover (Munoz-Her-
nandez et al., 2019).Cell Reports 36, 109317, July 6, 2021 ª 2021 The Author(s). 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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additional adaptor complex formed by TELO2 (Takai et al., 2007)
and its associated proteins TTI1 and TTI2 (Takai et al., 2010),
known as TTT. Recruitment of TTT to R2TP is thought to be
mediated through interaction of a CK2-phosphorylated acidic
motif in the flexible linker connecting the N- and C-terminal do-
mains of TELO2, with the PIH domain of PIH1D1 (Horejsı́ et al.,
2014; Horejsı́ et al., 2010; Pal et al., 2014). TELO2 interaction
with PIKKs has itself been suggested to be dependent on
HSP90, although the mechanistic basis for this has not been
defined (Takai et al., 2010).
We show that contrary to expectations TTT can be directly re-
cruited to R2, and we have determined the structure of the hu-
man R2-TTT complex by single-particle cryo-EM. The structure
permits atomic modeling of the RUVBL1 and RUVBL2 and
tracing of the a-helical repeats that form the solenoid structures
of the TTT proteins. Our data reveal a direct engagement of the
RUVBL1-RUVBL2 heterohexamer by the TTT complex that is in-
dependent of the RPAP3-PIH1D1 (TP) components. TTT inter-
acts with two DII domains from consecutive RUVBL1 and
RUVBL2 subunits, and this constrains the conformational flexi-
bility of the DII domains of the RUVBL proteins in the ADP-bound
state, inhibits the conformationally coupled activity of the RUVBL
AAA+ ATPase, and disturbs the engagement of PIH1D1 to the DII
domains. We show that TTT is fully competent to bind a strongly
R2TP-dependent PIKK client, TOR, but does so without inhibit-
ing TOR kinase activity. Taken together, our cryo-EM structures
and biochemical experiments reveal that TTT couples the
recruitment of TOR to the R2TP chaperone with the regulation
of the chaperone.
RESULTS
Cryo-EM of the RUVBL1-RUVBL2-TTT complex
Although current models suggest that TTT recruitment to R2TP is
mediated by the specific interaction of PIH1D1 with a CK2 phos-
phorylation site on TELO2 (Horejsı́ et al., 2014), we found that we
could readily pull down complexes of TELO2-TTI1-TTI2 with
strep-tagged RUVBL1-RUVBL2 (R2-TTT) in the absence of
RPAP3 and PIH1D1 (Figure 1A) and that R2 and TTT co-migrated
in size-exclusionchromatographyasa stablecomplex (Figure1B).
The TTI1-TTI2 subcomplex (henceforth TT) was also co-precipi-
tated by RUVBL1-RUVBL2 (R2-TT), demonstrating that TELO2
was also not required for complex formation (Figure 1A).
The assembled R2-TTT complex was vitrified by plunging into
liquid ethane, and Titan Krios microscopes equipped with Gatan
K2 detectors were used to collect cryo-EM data. 2D averages
showed that TTT occupies the DII face of the RUVBL1-RUVBL2
ring (Figure 1C). First observations during 3D refinement of the
cryo-EM data revealed that TTI1-TTI2-TELO2 binds to the DII
domains of consecutive RUVBL1 and RUVBL2 subunits, and
that we could saturate each R2 ring with up to three TTTs by
increasing the TTT-versus-R2 ratio during incubation. We ex-
ploited the presence of several copies of TTT per particle making
use of a symmetry expansion strategy (see STAR Methods and
Figure S1). We also observed that TTT attaches flexibly to the
DII domains and we split the volume into two bodies. One
body contained the ATPase ring of R2 without the flexible DII do-2 Cell Reports 36, 109317, July 6, 2021mains, and this refined to a resolution of 3.4 Å. The second body
included TTT and the twoDII domainsmaking direct contact with
TTT, and this reached an average resolution of 5.0 Å (Figure S2).
Then we built a composite map combining both bodies
(Figure 1D).
In the cryo-EM map we could readily identify the heterohexa-
meric ring formed by RUVBL1 and RUVBL2, but, in addition,
there is a strong body of density at the edge of the ring, projec-
ting over the face that bears the RUVBL-DII domains, corre-
sponding to TTT (Figure 1D). TELO2, TTI1, and TTI2 are known
or predicted to contain substantial regions of HEAT repeat (Kai-
zuka et al., 2010; Takai et al., 2010), and the density for TTT ap-
pears as a large curved arc containingmore than 30 a helices in a
solenoid arrangement that becomes increasingly poorly defined
at one end (magenta), a smaller segment of 20 a helices that
lies on top of the large segment toward the less well-ordered
end (orange), and a second shorter curved arc in which at least
15 helices can be identified, which abuts the well-ordered end
of the large arc (blue) (Figure 1D).
Based on its size (Figure 1E), we identified the larger segment
as TTI1; however, the attribution of the two smaller segments as
TTI2 or TELO2 was less clear. We identified TELO2 within the
three segments of helical solenoids by obtaining a reconstruc-
tion from an R2-TT pull-down complex that lacks TELO2. While
this was only of limited resolution (9 Å), density corresponding
to much of the helical solenoids was evident (Figure S2). Howev-
er, when the R2-TT map was compared with that for the R2-TTT
complex, the segment in orange was not observed, even at a
very low contour level, suggesting that it is due to the absence
of TELO2 in the R2-TT complex. R2 does not contact TELO2
directly, which agrees with our observation that TELO2 is
dispensable for the interaction of TT with R2 (Figure 1A).
The cryo-EM map revealed that TTT engages simultaneously
with the DII domains from consecutive RUVBL1 and RUVBL2
subunits of the R2 ring (Figure 2A), primarily contacting the OB
folds of the DII domains, which are themselves flexibly attached
to the core of the ring. No direct contact between TTT and the
highly ordered AAA+ ATPase core of the ring is evident. To test
the importance of the DII domains in the recruitment of TTT,
we generated an R2 complex from DDII mutants of each RUVBL
subunit in which the antiparallel b strand connecting the DII
domain to the ATPase core was truncated to a hairpin, thereby
eliminating the pendant OB-fold region. This truncated R2 has
been shown to oligomerize in the sameway as the wild-type pro-
tein (Gorynia et al., 2011). While a glutathione S-transferase
(GST)-tagged TTT complex co-precipitated wild-type R2 in
pull-down experiments, it failed to co-precipitate the DDII R2,
confirming that the OB folds of the DII domains are required for
the interaction with TTT (Figure 2B). However, in the inverse
experiment, the GST-tagged TTT was unable to effectively
bind the RUVBL1 and RUVBL2 DII domains when isolated from
the R2 complex of both subunits, either in pull-down experi-
ments (Figure 2C) or size-exclusion chromatography (Figure S3).
Taken together, these results show that the DII domains mediate
the recruitment of TTT into the R2-TTT super-complex, but only
when presented in combination within the defined spatial config-
uration of the heterohexameric R2 ring, as suggested by the
cryo-EM structure.
Figure 1. Cryo-EM of the human RUVBL1-RUVBL2-TTT complex
(A) Coomassie-stained SDS-PAGE gel showing analysis of interaction of RUVBL1-RUVBL2 (R2), TTI1-TTI2-TELO2 (TTT), and TTI1-TTI2 (TT) subcomplexes. Pull-
down on the strep-tag attached to the C terminus of RUVBL2 co-precipitates TTT and TT subcomplexes, showing that neither RPAP3, PIH1D1, nor TELO2 is
required to couple TTI1-TTI2 to R2. TTT and TT are not pulled down in the absence of R2.
(B) Coomassie-stained SDS-PAGE of fractions from a size-exclusion chromatography column for the human RUVBL1-RUVBL2 complex, R2, (top panel), the TTT
complex (middle panel), and the mixture of R2 and TTT (bottom panel). In the mixture, both R2 and TTT elute in earlier fractions than when loaded separately.
(C) Representative 2D average of R2-TTT cryo-EM data.
(D) Views of human R2-TTT volume. RUVBL1-RUVBL2 hexamer, green and yellow respectively. Three distinct a-helical segments (TTI1, magenta; TTI2, blue; and
TELO2-N, orange) are identifiable in the cryo-EM reconstruction after multi-body refinement of the R2-TTT complex.
(E) Schematic showing the relative lengths of the TTT components TTI1, TTI2, and TELO2. All three proteins are known or thought to be entirely composed of
HEAT repeats, which are interrupted by an ~70-residue flexible linker in TELO2 that connects the N- and C-terminal domains.




Figure 2. RUVBL1-RUVBL2 DII domains mediate TTT interaction
(A) View of human R2-TTT volume colored as in Figure 1D, highlighting the
contacts between the DII domains in two consecutive RUVBL subunits and the
elongated TTT subcomplex.
(B) Coomassie-stained SDS-PAGE gel showing analysis of dependence of the
interaction of TTI1-TTI2-TELO2 (TTT) with RUVBL1-RUVBL2 on the RUVBL1/2
DII domains. Pull-down on the GST-tag attached to the N terminus of TELO2
co-precipitates TTI1-TTI2 andwild-type RUVBL1/2, but not the RUVBL1/2DDII
complex where the DII domains have been excised.
(C) As in (B), but showing that the isolated DII domains of RUVBL1 and RUVBL2,
individually or in combination, are not co-precipitated by GST-TELO2-TTI1-TTI2
(GST-TTT) when not presented as part of the RUVBL1/2 heterohexamer.
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We built an atomic model of TTT by assigning regions of HEAT
repeat in the cryo-EM map and resolving uncertainties by map-
ping interactions between truncated versions of the TTT compo-
nents. The crystal structure of an engineered construct of yeast
Tel2p (Takai et al., 2010) consists of two helical solenoid seg-
ments of 19 and 9 helices, respectively, separated by 60 un-
structured residues that include the phosphorylated binding
motif for the PIH domain of Pih1p (Horejsı́ et al., 2014; Pal
et al., 2014). The size and shape of the segment assigned to
TELO2 in the cryo-EM structure (Figures 1D and 2A, orange)
correspond well with the structure of the larger N-terminal
segment of yeast Tel2p, and a homologous model of the corre-
sponding region of human TELO2 could be readily docked into
this density in the R2-TTT map as a rigid body (Figure 3A). The
substantial interface between the TELO2 N-terminal domain
(TELO2-N) and TTI1 is consistent with the identification of the
N-terminal segment of Tel2p rather than the C-terminal segment
as the main interactor with Tti1p-Tti2p (Takai et al., 2010). Based
on this, we can then attribute the remaining segment of HEAT re-
peats to the500 residues of TTI2. No significant density feature
is evident that could correspond to the smaller C-terminal region
of TELO2. As this region does not bind TTI1-TTI2 directly, and
connects to the N-terminal domain by a long flexible linker con-
taining the CK2 phosphorylation site implicated in interactions
with the PIH domain of PIH1D1, we conclude that it is disordered
in the present structure.
No prior structures are available for TTI1 or TTI2 or homologs
thereof, intact or in part. While the local resolution of the maps in
these regions (4.5–5Å) is sufficient to define the positions and to-
pological connection of the a helices making up the HEAT re-
peats that constitute most of these two proteins, it is not high
enough to allow assignment of amino sequence or the orienta-
tion of the Ca-Cb vectors of the side chains, which indicates
the N/C polarity of the helix. Consequently, the direction of
the polypeptide chain in the a-helical solenoid cannot be directly
determined.
To solve this problem, we took advantage of the effectively
linear mapping of primary to tertiary structure in a-helical sole-
noid architectures such as the HEAT repeats that are predicted
to form the majority of TTI1 and TTI2. One end of the helical den-
sity ascribed to TTI2 comes into close contact with one end of
the long arc of helical density ascribed to TTI1. To determine
which end of the TTI1 sequence this corresponds to, we co-ex-
pressed separate strep-tagged N-terminal (1–459) and C-termi-
nal (468–1089) parts of TTI1 with GST-tagged full-length TTI2 in
insect cells. Strep-TTI1-Cwas clearly recovered along with GST-
TTI2 in glutathione bead pull-downs from TTI1-C-expressing
cells, whereas no strep-TTI1-N was observed in similar experi-
ments with the TTI1-N-expressing cells (Figure 3B). Correspond-
ingly, GST-TTI2 was co-precipitated with strep-TTI1-C, but
neither strep-TTI1-N nor GST-TTI2 was recovered by strep-tag
pull-down from strep-TTI-N-expressing cells (Figure S4). In a
similar experiment we co-expressed full-length TTI1 in insect
cells, with either the N-terminal (1–193) or C-terminal (194–508)
part of TTI2 as a C-terminal fusion to GST. We found that the
GST-TTI2-N was highly expressed as a soluble protein, and it
co-purified full-length untagged TTI1 in glutathione bead
Figure 3. Molecular modeling of TTT and its
interaction with RUVBL1-RUVBL2
(A) Molecular model of TTT fitted within the cryo-EM
density of R2-TTT (transparent density). Individual
helices of TTI1 and TTI2 were fitted manually into
density using COOT and connected into a contin-
uous structure by taking advantage of the repeti-
tious linear right-handed a-solenoid architecture of
HEAT repeats. The polarity of the two polypeptides
was determined by the results of the interaction
mapping experiments shown in (C) and (D). The fit
of the poly-alanine structures was optimized by
real-space refinement in Phenix (Adams et al.,
2010). A homology model of the N-terminal domain
of human TELO2 based on the crystal structure of
S. cerevisiae Tel2p (Takai et al., 2010) was manually
adjusted to fit the experimental density using COOT
(Emsley and Cowtan, 2004). The TTT model was
optimized by real-space refinement in Phenix
(Adams et al., 2010). Each protein is colored as a
rainbow from N- to C-terminal ends.
(B) Co-expression of GST-tagged full-length TTI2
with TTI1 constructs spanning residues 1–459 (TTI1-
N) and residues 468–1089 in Sf9 insect cells. Only the
TTI1-C construct was co-precipitated as a soluble
species with GST-TTI2, suggesting that TTI2 pri-
marily interacts with the C-terminal half of TTI1.
(C) Co-expression of full-length TTI1 with GST-
tagged TTI2 constructs spanning residues 1–193
(TTI2-N) and residues 194–508 (TTI2-C) in Sf9 insect
cells. The GST-tagged TTI2-N was well expressed
as a soluble species and co-precipitated TTI1 in
GST pull-downs, whereas co-expressed TTI1 and
GST-TTI2-C were primarily found in the insoluble
fraction. This suggests that TTI1 primarily interacts
with the N-terminal half of TTI2.
(D) Close-up of electron density in the core of the
RUVBL2 subunit that contacts TTI1 and TTI2,
showing clear electron density for side chains. The
fit of the all-atom model of the RUVBL1-RUVBL2
heterohexamer was optimized by real-space
refinement in Phenix.
(E) Close-up of electron density in the nucleotide-
binding site of the RUVBL1 subunit that contacts
TTI1, showing bound ADP. All six nucleotide-
binding sites in the R2 ring are fully occupied
by ADP, and the His-Ser-His motif that closes
off the nucleotide-binding site as part of the N-ter-
minal ‘‘gatekeeper’’ segment (Munoz-Hernandez
et al., 2019) is also fully ordered in all six ATPase
subunits.
(F) Interaction of TTI1 (rainbow-colored helices) with
the DII domain of a RUVBL1 subunit (magenta). The
fit of the all-atom model of the RUVBL1-RUVBL2 heterohexamer and the TELO2-N domain as well as the poly-Ala models of TTI1 and TTI2 were simultaneously
optimized by real-space refinement in Phenix against a ‘‘consensus’’ electron density map comprisingmaps from separatemultibody and focused refinements of
the R2 rings and TTTwith the interacting DII domains. In an XL-MS analysis of R2TP-TTT, a single cross-link was observed between RUVBL1-Lys171 (black circle)
and Lys461 of TTI1. Although the resolution of the TTI1 density does not permit fitting of the sequence, the crosslink helps localize the approximate location of
TTI1-Lys461 (red ellipse).
(G) Interaction of TTI1 (cyan helices) and TTI2 (green helices) with the DII domain of a RUVBL2 subunit. The DII domain packs into the cleft formed at the junction of
the a-helical solenoids of the two HEAT repeat proteins.
(H) Human RUVBL1-RUVBL2 displays a weak inherent ATPase activity with amaximal rate of ~0.6mol/min/mol. This is significantly diminished in the presence of
TTT at a 3:1 molar ratio. Error bars indicate the standard error of the mean of three experiments.
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detectable in the soluble fraction and did not co-precipitate
TTI1 (Figure 3C). Taken together, these results indicate that theTTI1-TTI2 interface involves the N terminus of TTI2 binding to
the C terminus of TTI1 with the more central/N-terminal part of
TTI1 providing the binding site(s) for the TELO2 N-terminalCell Reports 36, 109317, July 6, 2021 5
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or homology models of RUVBL1, RUVBL2, TELO2-N, and the
helical repeats of TTI1 and TTI2 into the cryo-EMmaps and opti-
mize the atomic fits using restrained real-space refinement in
phenix.refine (Adams et al., 2010) and manual adjustment in
COOT (Casanal et al., 2020).
RUVBL1-RUVBL2–TTT Interactions regulate ATPase
activity
The structure of the RUVBL1-RUVBL2 ring (maximum resolution
3.41Å) within the overall human complex is similar to that previ-
ously described in the R2TP complex (Martino et al., 2018; Mu-
noz-Hernandez et al., 2019).The amino acid sequence of all six
subunits is well resolved with clear side-chain density evident
for most of the polypeptide chain (Figure 3D), apart from the
DII insertion domains. Two of these, which interact with the
TTT proteins, are resolved at resolutions in the 4.5–7.5 Å range,
while the other four are substantially disordered. All six subunits
have clear density for bound ADP, with the N-terminal ‘‘gate-
keeper’’ segment of polypeptide incorporating the His-Ser-His
motif, well ordered and interacting with the bound nucleotide
(Munoz-Hernandez et al., 2019) (Figure 3E).
Although recruitment of TELO2 (Tel2p in yeast), and by pre-
sumption the entire TTT subcomplex, to R2TP was thought to
depend on interaction of a conserved CK2 phosphorylation
site in TELO2/Tel2p with the PIH domain of PIH1D1/Pih1p
(Horejsı́ et al., 2014; Horejsı́ et al., 2010; Pal et al., 2014), our
3D structures and supporting biochemistry clearly show sub-
stantial direct interactions between elements of the TTT sub-
complex and the RUVBL ring that are completely independent
of the TP components—RPAP3/Tah1p and PIH1D1/Pih1p—
and are sufficient to form stable R2-TTT and R2-TT complexes.
At the heart of the TTT interface with R2, the concave inner sur-
face of TTI1 wraps around the OB fold of the projecting DII
domain of a RUVBL1 subunit, which contacts helices from the
central part of the TTI1 solenoid, on the face opposite to the
binding site of the TELO2-N segment (Figure 3F). Consistent
with this arrangement, we identified a single cross-link between
RUVBL1 and TTI1 in a cross-linking mass spectrometry (XL-MS)
analysis of a putative human R2TP-TTT complex (Figure S4),
connecting Lys171 of RUVBL1 with Lys461 of TTI1. While the
resolution of the TTI1 density does not allow this residue to be
pinpointed with any precision, it does localize it to a region en-
compassing one or two helical segments in the fitted model
and helps establish the approximate staging of the sequence
along that model. Simultaneously, the DII domain of the clock-
wise adjacent RUVBL2 subunit packs into the V-shaped cleft
formed at the junction of the predicted C terminus of TTI1 and
the predicted N terminus of TTI2 (see above), interacting with he-
lices from the convex faces of both proteins (Figure 3G). As
essentially all the contacts between the TTT subcomplex and
the R2 ring are mediated by the DII domains, which are them-
selves very flexibly attached to the AAA+ ATPase core, there is
substantial conformational variability in the relative orientation
of the TTT and R2 components as revealed by multi-body refine-
ment (Nakane et al., 2018).
We previously showed a direct coupling between the confor-
mation of an N-terminal region in RUVBL2 containing the His-6 Cell Reports 36, 109317, July 6, 2021Ser-His motif that binds nucleotide (Figure 3E) and the confor-
mation of DII domains, which was promoted by their interaction
with PIH1D1 (Munoz-Hernandez et al., 2019). This was shown to
affect the binding of nucleotides to regulate nucleotide exchange
as part of the AAA+ ATPase cycle. As the TTT complex makes
extensive interaction with the DII domains of a pair of consecu-
tive RUVBL1 and RUVBL2 proteins in the heterohexameric
ring, we explored whether TTT binding influenced the AAA+
ATPase cycle. Using a sensitive malachite green phosphate-
release assay, we were able to measure a basal ATPase activity
with Vmax0.6 mol/min/mol for human RUVBL1-RUVBL2, which
was substantially diminished by addition of a 3:1 molar equiva-
lent of TTT (Figure 3H). Therefore, TTT directly binds RUVBL
and modulates its ATPase activity.
PIH1D1/Pih1p and TTT compete for the interaction with
RUVBL1-RUVBL2
TTT is assumed to function in the context of R2TP, a complex
where R2 also binds RPAP3-PIH1D1 (TP). As we have previously
shown that PIH1D1 also interacts with the DII domains of R2, we
explored whether TTT and PIH1D1 compete for interaction with
R2 or can be accommodated together within a super-complex.
For this, we assembled the human R2TP-TTT complex for
cryo-EM studies by mixing separately purified R2TP and TTT
complexes and the mix was analyzed by cryo-EM.
We obtained a reconstruction for the R2TP-TTT complex with
an average resolution of 6.1 Å in which, as well as a bound TTT
subcomplex, we could readily identify two well-defined copies
of the C-terminal RBD of RPAP3 bound to the AAA face of the
RUVBL1-RUVBL2 ring (Martino et al., 2018; Maurizy et al.,
2018) (Figure 4A; Figure S5). As with previous studies, a third
RBD was evident at a lower contour level. The structural organi-
zation of TTT in R2TP-TTT was essentially identical to that
observed in the R2-TTT complex. In R2TP, whereas three
RPAP3-PIH1D1 complexes can be tethered to each RUVBL1-
RUVBL2 ring at a time due to the interaction of the RPAP3-
RBD domain to each of the three RUVBL2 subunits, only one
PIH1D1 is effectively engaged to the DII domains (Martino
et al., 2018; Munoz-Hernandez et al., 2019). Interestingly,
although present in the in vitro assembled R2TP-TTT complex,
no density was evident for PIH1D1 at the binding site identified
in previous studies, nor for the conformationally flexible N-termi-
nal regions of RPAP3 (Martino et al., 2018; Munoz-Hernandez
et al., 2019). This suggests that TTT and PIH1D1 might compete
for the binding to the DII domains of R2.
To further support this hypothesis, we also assembled an
S. cerevisiae R2TP-TTT complex in vitro by mixing a pre-assem-
bled Rvb1p-Rvb2p-Pih1p-Tah1p complex with an equal con-
centration of a pre-assembled Tel2p-Tti1p-Tti2p complex where
the components were purified from insect cells to ensure sub-
stantial post-translational modifications on the Tel2p compo-
nent. Yeast TTT prepared in this way was co-precipitated in
pull-down experiments with Tah1p-Pih1p (Figure 4B), suggest-
ing that any phosphorylation required within the Tel2p motif pre-
dicted to bind the PIH domain of Pih1p was present on the sam-
ple. Cryo-EM data were collected and processed as above. 3D
classification of particles from this sample revealed a more het-
erogeneous distribution than for the human samples, which
Figure 4. Cryo-EM of human and yeast R2TP-TTT complexes
(A) Two views of human R2TP-TTT volume: RUVBL1-RUVBL2 hexamer, green
and yellow respectively; TTI1, magenta; TTI2, blue; TELO2-N, orange. The
RPAP3 C-terminal RUVBL2-binding domain (RBD) is identifiable in the ATPase
face of each of the RUVBL2 subunits (red).
(B) Coomassie-stained SDS-PAGE gel showing analysis of interaction of yeast
Tah1p-Pih1p (yTP), Rvb1p-Rvb2p (yR2), and Tel2p-Tti1p-Tti2p (yTTT) sub-
complexes. Pull-down on the tandem strep-tag attached to the N terminus of
Tah1p within the yTP complex co-precipitates yR2 and yTTT simultaneously
and as separate co-complexes.
(C) Cryo-EM analysis of co-precipitated Tah1p-Pih1p-Rvb1p-Rvb2p-Tel2p-
Tti1p-Tti2p (yeast R2TP-TTT). 3D classification yields two main classes: one
class contained particles with strong central density between the DII insertion
domains of the R2 ring comprising two-thirds of the particles (top), and the
other class resembled the previously described yeast R2TP complex (EMD-
3678) (Rivera-Calzada et al., 2017) (bottom).
(D) As in (C), but showing the second main class comprising two-thirds of the
particles, which lack the central density attributed to Tah1p-Pih1p, but display
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and higher resolution (6 Å) class possessed a strong centrally
positioned feature nestled between the DII domains of the R2
ring, but with no density corresponding to TTT, and it strongly
resembled the previously described yeast Rvb1p-Rvb2p-
Pih1p-Tah1p complex structure (Rivera-Calzada et al., 2017)
(Figure 4C). The second, less populated and lower resolution
class (10 Å) lacked the central feature, but it possessed a sub-
stantial additional density at the periphery of the R2 ring, which
resembled the human TTT density in the human R2TTT recon-
struction, and in which similar segments could be identified (Fig-
ure 4D). No significant classes were found in 3D classification in
which the central and peripheral density features were simulta-
neously present.
Therefore, our analysis of human and yeast R2TP bound to
TTT suggests that TTT and PIH1D1 compete for their interaction
with the DII domains.
TTT delivers TOR to the R2TP chaperone
While our data suggest that TTT also plays a role in regulating
the ATPase activity of the R2 ring, its main function is thought
to be as an adaptor, recruiting PIKK client proteins such as
TOR to the R2TP or R2 complex (Houry et al., 2018; Kakihara
and Houry, 2012; Muñoz-Hernández et al., 2018). To test this,
we purified S. cerevisiae TTT in which Tti1p carried a C-terminal
FLAG-tag and looked at its ability to interact with a TOR1-Lst8
complex from the closely related yeast Kluyveromyces marxia-
nus (the construct was a kind gift of Roger Williams, MRC-LMB,
Cambridge, UK), which has 83% sequence similarity to
S. cerevisiae TOR2, but is far more amenable to large-scale
expression and purification. We found that KmTOR was co-
immunoprecipitated by beads carrying an anti-FLAG antibody
in the presence of FLAG-tagged TTT, but not in its absence
(Figure 5A). KmLst8 was evident in the input TOR1 preparation
as a weak-staining band. Curiously, this bandwas less visible in
the immunoprecipitated material, but since Lst8 in our prepara-
tions is always much weaker staining in gels than its TOR part-
ner, we cannot conclude whether this reflects some effect of
TTT in the interaction between TOR and Lst8. FLAG-tagged
TTT was also able to simultaneously co-immunoprecipitate
KmTOR and R2when both components were present, suggest-
ing that KmTOR, R2, and TTT can form a complex (Figure S6).
To determine which components of the TTT complex are
required for interaction with the PIKK client, we separately ex-
pressed Tel2p and the constitutive Tti1p-Tti2p complex and
looked at their interaction with KmTOR. We found that KmTOR
was effectively co-precipitated with Tti1p - GST-Tti2p in a GST
pull-down experiment, but not by GST-Tel2p (Figure 5B). In
contrast to TTT, TP (Tah1p-Pih1p) or R2TP complexes in which
Tah1p carried a tandem strep-tag were unable to co-precipi-
tate KmTOR directly. However, strep-tagged TP could co-pre-
cipitate KmTOR when TTT was also present, demonstrating
that TTT can provide a bridging interaction between the two,strong peripheral density at one edge of the R2 ring (top) that strongly re-
sembles the density for the TTT complex in the higher resolution human R2TTT
structure (bottom). No significant class of particles was identified in which the
central and peripheral density features were simultaneously present.
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OPEN ACCESSin which the binding sites for TP and KmTOR on TTT are non-
overlapping (Figure 5C).
We also expressed and purified a FLAG-tagged construct of
human mTOR (mTORDN) that lacks most of the N terminus (res-
idues 1–1376) but retains the binding site for mLst8, and it dis-
plays essentially full kinase activity (Yang et al., 2013).We found
that the human TTT complex was co-immunoprecipitated by
beads carrying an anti-FLAG antibody, in the presence of a
FLAG-tagged mTORDN-mLst8 complex, but not in its absence
(Figure 5C). We also expressed and purified a soluble FLAG-
tagged segment of mTOR comprising the first 929 residues.
We found that this construct, which encompasses the main
HEAT repeat segment of mTOR, was not able to co-precipitate
human TTT (Figure 5E); however, this fragment was able to
interact with RUVBL1-RUVBL2 in the absence of TTT (Figure 6A).
Taken together, these data suggest that RUVBL1-RUVBL2
and TTT cooperate to bring TOR to the complex. The binding
site for TTT on TOR actually resides in the C-terminal kinase re-
gion, rather than in the N-terminal HEAT repeat region, as had
previously been suggested (Takai et al., 2007), and it primarily in-
volves a substantial direct contribution from TTI1/Tti1p-TTI2-
Tti2p rather than TELO2/Tel2p itself (Takai et al., 2010).
RUVBL1-RUVBL2 instead interacts with the mTOR N-terminal
HEAT repeat region.
Since TTT and R2 form direct complexes with mTOR, we
sought to determine whether these interactions affected the abil-
ity of TOR to phosphorylate its substrates. We used a phospho-
specific antibody to a highly conserved and well-characterized
TOR target phosphorylation site in 4E-BP1 (Wu et al., 2017) to
show that our purified yeast KmTOR1-Lst8 was active as a ki-
nase (Figure 6B) and was effectively inhibited by an ATP-
competitive mTOR inhibitor (Liu et al., 2009). However, we found
that addition of an excess of TTT or R2, or both together, had no
effect on the ability of KmTOR1 to phosphorylate 4E-BP1 (Fig-
ure 6C), suggesting that the interactions that these components
of the R2TTT complexmakewith TOR proteins do not have a role
in regulating TOR kinase activity directly.
DISCUSSION
The heterohexameric RUVBL1-RUVBL2 ring appears to provide
the central constant component of a multiplicity of chaperone
complexes each specific for a distinct class of client proteins
(Houry et al., 2018; Kakihara and Houry, 2012; Muñoz-Hernán-
dez et al., 2018). As with systems such as HSP90, with whichFigure 5. Mapping the interactions between TTT and TOR
(A) Coomassie-stained SDS-PAGE gel showing interaction of yeast (Kluyveromyc
immunoprecipitates TOR1, whereas anti-FLAG beads alone do not. Lst8, whic
immunoprecipitated TTT-TOR1.
(B) As in (A), but for interaction of KmTOR-Lst8 with GST-tagged Tti2p-Tti1p or G
GST-TTI2p, but not with Tel2p.
(C) As in (A), but for interaction of KmTOR-Lst8 with TP and R2TP complexes con
precipitate KmTOR directly. However, tagged TP could co-precipitate KmTOR
binding to TTT.
(D) As in (A), but for interaction of a FLAG-tagged N-terminally truncated human m
co-immunoprecipitated by FLAG-tagged mTORDN, but not by FLAG beads alon
(E) As in (A), but for interaction of a FLAG-tagged soluble N-terminal fragment of
with human TTT. Flag-tagged mTORHEAT was precipitated by FLAG beads, but iRUVBL1-RUVBL2 (R2) collaborates as a co-chaperone, client
specificity is thought to be mediated by scaffold proteins that
structurally couple the generalized core R2-ATPase complex to
the client. In both yeast and mammalian systems, the TELO2-
TTI1-TTI2/Tel2p-Tti1p-Tti2p (TTT) complex, whose structure
we describe herein, behaves as a classical scaffold adaptor, be-
ing able to independently bind a PIKK protein and the RUVBL1-
RUVBL2 ring (Figures 2 and 5).
Current models suggest that recruitment of TTT to R2 is medi-
ated by the interaction of a conserved phosphopeptide motif
within the intrinsically disordered linker segment of TELO2/
Tel2p, which binds to the PIH domain of PIH1D1/Pih1p (Horejsı́
et al., 2014; Horejsı́ et al., 2010; Pal et al., 2014) in the TPR pro-
tein-PIH (TP) component of an R2TP-TTT super-complex. How-
ever, our structural and biochemical data clearly show that hu-
man TTT is fully able to bind R2 in the absence of PIH1D1 and
RPAP3 (Figure 1), so while this interaction may contribute to
the function of the system, it is not essential for TTT recruitment.
In the human system, the TTT and TP subcomplexes are able to
coexist simultaneously in a complex with the same R2 ring, as
demonstrated by the clear presence of density for RPAP3-
RBD domains on the ATPase face of the R2 ring to TTT in
cryo-EM reconstructions (Figure 4A). However, no density was
evident that would correspond to the expected location, based
on our previous structural analysis (Munoz-Hernandez et al.,
2019) of PIH1D1 attached to one of those RPAP3 molecules
and engagedwith theDII side of the R2 ring. The absence of den-
sity for PIH1D1, although present in the complex through its
constitutive association with RPAP3, suggests that binding of
TTT and PIH1D1 to the DII face of the R2 ring may be mutually
exclusive.
In the low-resolution yeast cryo-EM data, we identify only two
classes of particles, in which either TP or TTT subcomplexes, but
not both, are bound to the DII face of the R2 ring (Figures 4C and
4D). The absence of any substantial set of particles displaying
density for both TP and TTT components implies that as in the
human system, binding of these components to the R2 ring is
mutually exclusive.
Taken together, our observations for human and yeast sys-
tems suggest that TTT and TP components are alternative R2 li-
gands engaging with the DII face of the ring with mutual exclusiv-
ity. However, the independent pairwise interactions of the TTT,
TP, and R2 components keep the non-engaged component
tethered to the overall complex. In the yeast system, this teth-
ering is provided by binding of the PIH domain of Pih1p in thees marxianus) TOR1-Lst8 with yeast (S. cerevisiae) TTT. FLAG-tagged Tti1p co-
h is evident as a weakly staining band in the input, was not evident in the
ST-tagged Tel2p. KmTOR was co-precipitated in GST pull-down with Tti1p-
taining strep-tagged Tah1p. Neither TP nor R2TP complexes were able to co-
when TTT was present, confirming that TP and KmTOR do not compete for
TOR construct (mTORDN) co-expressed with mLST8, with human TTT. TTT is
e.
human mTOR encompassing the major segment of HEAT repeats (mTORHEAT)
t did not co-immunoprecipitate TTT.
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Figure 6. TTT couples mTOR recruitment to
R2TP to regulation of the chaperone
(A) Coomassie-stained SDS-PAGE gel showing
the interaction of an mTOR fragment comprising
the N-terminal HEAT region (residues 1–929) with
the strep-tagged RUVBL1-RUVBL2 complex.
(B) Western blot showing phosphorylation of 4E-
BP1 by the yeast (K. marxianus) TOR1-Lst8 com-
plex. A strong signal was detected by a phospho-
specific antibody to pThr37/46 in the presence of
ATP, but not when ATP was omitted from the re-
action, or when the ATP-competitive mTOR inhibi-
tor dactolisib (NVP-BEZ235) was present.
(C) As in (B), but with the addition of TTT, R2, or both.
Neither of these chaperone components, alone or in
combination, affects its ability to phosphorylate a
substrate.
(D) Model of the functions of TTT. Flexible tethering
to the R2 ring allows for facile exchange of TP
and TTT components at the main interaction site on
the DII domain face of the ring. Interaction of the
PIH1D1 part of TP with a RUVBL1 DII domain
facilitates partial ring opening and nucleotide
exchange (Munoz-Hernandez et al., 2019), accel-
erating the basal ATPase activity of the ring (Rivera-
Calzada et al., 2017). The CK2 phosphorylation site
within the inherently disordered linker connecting
the N- and C-terminal domains of TELO2 (Horejsı́
et al., 2010) tethers the TTT subcomplex to the R2
ring through interaction with the PIH domain of
PIH1D1 (Horejsı́ et al., 2014; Pal et al., 2014) and
thereby facilitates recruitment of a PIKK client to the
core complex (top). Rearrangement of the complex
allows TTT to bind to the DII domains of consecutive
RUVBL1-RUVBL2 domains, fixing them in an ADP-
bound closed state that downregulates the basal
ATPase, potentially bringing the PIKK client into
closer association. Steric hindrance of the DII do-
mains, as well as allosteric incompatibility, prevents
simultaneous binding of PIH1D1 to the DII face of
the ring. Although not engaged, TP remains teth-
ered to the complex through the interaction of the
PIH domain with the TELO2 linker segment (see
above) and the interaction of the C-terminal domain




OPEN ACCESSTP component to a putative CK2 phosphorylation site within an
intrinsically disordered segment of 50 residues that links the
N-terminal and C-terminal domains of Tel2p. In the human sys-
tem, in addition to the equivalent interaction of the PIH1D1 PIH
domain and the CK2 phosphorylation site in the longer 70-res-
idue TELO2 linker segment, the TP component is also tethered
by the C-terminal RBD domain of RPAP3, which connects by
an intrinsically disordered segment of100 residues to the bind-
ing motif of for the CS domain (Henri et al., 2018) (Figure 6D).
This flexible tethering mechanism might serve to allow the
non-engaged component to nonetheless remain associated
with the overall complex and poised to exchange with the
engaged component as required. We previously showed that
binding of the TP component accelerated the inherent ATPase
of the R2 ring (Rivera-Calzada et al., 2017), probably by promot-10 Cell Reports 36, 109317, July 6, 2021ing ring opening to facilitate nucleotide exchange (Munoz-Her-
nandez et al., 2019). In this study, we show that binding of the
TTT complex has the converse effect, decreasing ATP turnover
by stabilizing the ring in a closed ADP-bound state. The flexible
exchange of TP and TTT subcomplexes might therefore function
in regulating the ATPase activity of the system at different stages
of loading, manipulation, and release of a PIKK client protein;
however, further work is required to test this idea.
TELO2/Tel2p and the associated TTI1/Tti1p-TTI2/Tti2p are
implicated in the activation and stabilization of most, if not all,
members of the PI3K-like kinase family (Takai et al., 2007). These
proteins share strongly conserved C-terminal kinase regions
attached to more diverse N-terminal segments composed of
HEAT repeats. Paradoxically, a previous cell-based interaction
analysis using expressed fragments of mTOR or ATM implicated
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with TELO2 (Takai et al., 2007). Using purified and soluble seg-
ments of mTOR, we find instead that it is the strongly conserved
kinase-containing C-terminal region that is recognized by the
TTT complex. However, this interaction does not inhibit kinase
activity, indicating that it neither allosterically regulates TOR
nor prevents access of substrate to its active site (Figure 6C).
While we cannot dismiss the possibility that parts of the HEAT
repeats of particular PIKKs may contribute to their individual
interaction with TTT, the primary involvement of the common
and highly conserved kinase region provides a more evolution-
arily compelling explanation for the selectivity of the TTT compo-
nent of this chaperone/co-chaperone system. Nonetheless,
RUVBL1-RUVBL2 binds independently of TTT to the N-terminal
HEAT regions in mTOR, suggesting that both TTT and R2 com-
ponents collaborate to mediate PIKK interactions.
Taken together, our results reveal the architecture of the TTT
complex and show how TTT couples R2TP’s recruitment of
PIKKs to the regulation of the chaperone’s ATPase activity.
The structural details of the interaction of TTT and its complexes
with PIKKs and their complexes remain to be determined. How-
ever, the ability of TTT to interact with fully folded and catalyti-
cally competent mTOR is consistent with previous observations
that interaction with TTT is not required for folding, but instead
contributes to the assembly of the larger multiprotein complexes
in which PIKKs such as mTOR are key components (Takai et al.,
2010). Further work is required to uncover how R2TP-TTT facil-
itates that process.STAR+METHODS
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Martino, F., Pal, M., Muñoz-Hernández, H., Rodrı́guez, C.F., Núñez-Ramı́rez,
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code: PDB: 7OLE. The composite cryoEM volume for R2TP-TTT and R2-TTT has been deposited in the Electron Microcopy Data-
bank (EMDB) with accession code: EMD:12957 and EMD:12979 respectively.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Bacterial strains and growth conditions
The bacterial cells, BL21 (DE3) pLysS (cat# 10604973), DH5a (cat# 11583117) and DH10Bac (cat# 10361-012) were purchased from
Thermo Fisher Scientific. For protein expression, BL21 (DE3) pLysS cells were transformedwith plasmids encoding different genes of
the R2TP complex. The transformed cells were spread on LB agar plates containing ampicillin and kanamycin antibiotics. The plates
were incubated at 37C overnight, and a single colony of these transformed cells was used to grow starter culture for protein expres-
sion at a large scale (10L). The cells were grown in LB media containing ampicillin and kanamycin antibiotics. For future protein
expression, these transformed cells were stored as 40% glycerol stocks at 80C.
Virus and its propagation
Bac-to-Bac system was used to generate the baculoviruses, which were used to infect Sf9 cells. The bacmid DNA samples were
stored at 20C. The propagated baculoviruses were stored at 4C supplemented with 2% Foetal Calf Serum (Sigma-Aldrich cat
# 12133C).
Spodoptera frugiperda 9 (Sf9) cell growth conditions
For the insect cell protein expression, Sf9 cells (Spodoptera frugiperda 9) were purchased from Thermo Fisher Scientific (cat#
11496015). Sf9 cell culture of 4 3 105 cells/ml was added to the 500ml of Insect-Xpress media containing Streptomycin/Penicillin
(Lonza) antibiotics in a 2L roller bottle. The cell culture was incubated at 27C with 150rpm until the cell density reached 2x 106
cells/ml. Then the cells were infected with titered viruses expressing proteins of interest. The infected cells were further grown for
72h at 27C using 150rpm rotation. The cells were pelleted by spinning 2000 x g (rotor JLA 8.1) for 10min, at 4C. The cell pellet
was frozen at 80C for long term storage.
Yeast cell growth conditions
The Kluveromyces marxianus yeast strain (ATCC22296, LGC Standards Ltd., UK) expressing KmTOR1-KmLst8 was a gift
from Dr Roger Williams (LMB, University of Cambridge). The cells were grown in yeast extract peptone (YEP) media supple-
mented with 2% glucose at 37C and 220rpm. The protein expression and purification were carried out according to the
published protocol by Dr Roger Williams’ lab (Baretic et al., 2016). The K. marxianus strain was stored as 40% glycerol stock




The bacterial strain BL21 (DE3) pLysS was used to express yeast Tel2p proteins. The human and yeast TTT (Tel2-TTI1-TTI2) protein
complexes, and human mTORN and mTORDN-Lst8 were expressed in Sf9 cells. The Kluveromyces marxianus yeast was used to ex-
press full-length KmTOR1-Lst8 complex.
Gene cloning and protein expression and purification
Yeast (Saccharomyces cerevisiae) and human R2 (RUVBL1/2 or Rvb1/2) and TP (RPAP3-PIH1D1 or Tah1p-Pih1p) were expressed
and purified as previously described (Martino et al., 2018; Rivera-Calzada et al., 2017). Kluveromyces marxianus KmTOR-KmLst8
were purified as described in (Baretic et al., 2016). Human and yeast TELO2/Tel2p were cloned into pFBDM plasmid as BamHI
and EcoRI fragments, respectively, in fusion with a GST-tag. The yeast Tel2p was also cloned into p3E (Sussex University) using
NdeI and BamHI fragment resulting into GST-Tel2p which was co-overexpressed with CKII (Sussex University) in BL21 (DE3) pLysS
cells (Thermo Fisher Scientific). TTI1 and GST-TTI2 were cloned into pFBDM plamid as XhoI-KpnI and BamHI-EcoRI fragments,
respectively (Genscript). Strep-TTI11-459 and Strep-TTI1468-1089 were cloned into pFBDM-GST-TTI2 plasmid for coexpression.
GST-TTI21-193 and GST-TTI2194-508 and GST- mTOR
N (residues 1-929) were cloned into BamHI and EcoRI in pFBDM-TTI1 plasmid
for Spodoptera frugiperda (Sf9) expression. The mTORDN (residues 1376 to 2549) containing 6XHis-2XFlag-PreScission cleavable
tag at its 50 was purchased fromGenscript and cloned into BamHI and EcoRI sites of pFBDMand 50 2XFlag-6XHis-PreScission cleav-
able tagged-mLst8 gene was cloned as XhoI and KpnI fragment into pFBDM plasmid. TTI1-TTI2, full length as well as truncated ver-
sions andmTORDN,mTORN complexeswere overexpressed in Sf9 cells. For the co-expression of the yeast and human TTT complex,
mixed viruses of yeast and human TTI1-TTI2/Tti1p-Tti2p and TELO2/Tel2p were used to co-infect Sf9 cells. Cell pellets containing
yeast Tel2p were disrupted by sonication, while those containing TTI1-2 complex were lysed using a cell homogenizer in 20 mM
HEPES pH 7.5, 250 mM NaCl,0.5mM TCEP (HEPES buffer) and 1 tablet of EDTA free protease inhibitors (Roche, 11697498001).
The cell lysate was centrifuged at 21,000 g for an hour 4C. The clear supernatant was added to equilibrated GST beads in HEPES
buffer for affinity chromatography. The proteins were eluted using 50mM reduced glutathione from the GST beads. The GST-tag was
cleaved with PreScission protease at 4C overnight. The quality of the protein complexes was analyzed using SDS-PAGE and the
protein complexes were further purified by gel filtration using Superdex 200 increase 10/300 GL (GE healthcare) and Superose 6
10/300 (GE healthcare) column equilibrated in the HEPES buffer.
For the DII domain deletion experiments, genes encoding 3xmyc-RUVBL1 and 3xmyc-RUVBL1DDII were cloned into pRSETA
using the NheI sites. The 6xHis-RUVBL2 and 6xHis-RUVBL2DDII genes were cloned into pET28b plasmids using the NdeI sites.
6xHis-DII domains of the RUVBL1 and RUVBL2 were cloned into pCDFduet-1 plasmids using NdeI and KpnI sites and the human
GST-TELO2 gene was cloned into a pFBDM plasmid using BamHI and EcoRI sites. RUVBL1/2, their DDII domain versions, and
isolated DII domains were expressed in BL21 (DE3) cells and purified using Talon affinity chromatography in 50mM Tris-HCl,
pH 7.8, 300mM NaCl buffer. The proteins were further purified by gel-filtration (using HiPrep Sephacryl S-400 HR and S200
16/60 columns) in the same buffer. GST-TELO2 protein was expressed in Sf9 cells and was purified using GST affinity chromatog-
raphy in 20mM HEPES, pH 7.85, 500mM NaCl buffer and further purified by gel filtration using Superdex 200 Increase 10/300 GL
column.
Purification of the mTOR-KD-Lst8 complex and mTOR1-929 (heat repeat)
Human mTORDN (residues 1376 to 2549 with a His-Flag-PreScission cleavable tag at the N terminus) was co-expressed with full
length human Lst8 in Spodoptera frugiperda Sf9 cells. Cells were harvested and resuspended in lysis buffer containing 20 mM
HEPES, pH 7.85, 250 mMNaCl, 1 mMEDTA, 0.5 mM TCEP and supplemented with 1 tablet of EDTA free protease inhibitors (Roche,
11697498001).Cells were lysed, centrifuged at 21,000 g for 60min at 4C and then applied to 1mL of anti-FLAGM2 Affinity Gel-resin
(Sigma-Aldrich Ltd) and incubated for 60 min at 4C on a 200 rpm/min roller. The resin was then washed with 50 mL lysis buffer. The
bound mTORDN was released from the resin using 0.2 mg/ml flag peptide (Peptide synthetics) dissolved in lysis buffer.The flag-tag
was removed from mTOR-KD by incubating with PreScission protease at 4C overnight. The mTORDN was then concentrated and
further purified by gel-filtration using Superdex 200 increase 10/300 GL column in lysis buffer.
Interaction studies using pull-down experiments
For GST-tag affinity, strep-tag and flag-tag pull-down experiments, 40 mL beadswere equilibrated in 20mMHEPES, pH 7.85, 140mM
NaCl, 0.5mMTCEP, 0.03%CHAPS detergent. 20 mL of 1mg/ml of GST-TTI2-TTI1, yeast and human TTT proteins, 1mg/ml C-terminal
Strep-tagged RUVBL2 and 2xFlag- mTORN, KmTOR-KmLst8 were used for pulldown experiments. The subcomplexes were incu-
bated with either 40ul GST/Strep/Flag beads and incubated for 45mins at 4C rotating at 20 rpm The beads were washed three times
with 200 mL buffer by pelleting with quick centrifuge at 3000 g for 10sec. The quality of the pull-down interactions was visualized using
4%–12% SDS-PAGE in MES and MOPS buffer.
For the DII domain deletion experiments, GST beadswere equilibrated in 20mMHEPES, pH 7.85, 140mMNaCl and 0.001%Tween
20 buffer. 5 mMGST-TELO2 protein wasmixedwith 50ul of GST beads. For the pull-down experiments, 2 mMof RUVBL1/2, RUVBL1/
2DDII and isolated DIIs of RUVBL1/2 were added to the GST-TEL2 sample. For the negative control, 2 mMGST-tag alone was incu-
bated with above proteins. The complex was incubated for 45 mins at 4C rotating at 20 rpm/min. The beads were washed threeCell Reports 36, 109317, July 6, 2021 e3
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OPEN ACCESStimeswith 500 mL of 20mMHEPES, pH 7.85, 140mMNaCl and 0.001%Tween 20 buffer. The bound protein complexes were boiled in
Laemmli buffer and visualized on 4%–12% SDS-PAGE.
ATPase assay
The ATPase assay of RUVBL1-RUVBL2 was carried using PiColorLock detection reagent kit (Innova Biosciences Ltd). The ATPase
assay was carried out in 50mM Tris-HCl Ph 7.5, 50mM NaCl, 20mM MgCl2 0.1%Glycerol, 0.01% Tween X-100. All the ATPase re-
actions were carried out in triplicates. For each ATPase reaction, 0.25 mMRUVBL1-RUVBL2, and 1.2 mM-400 mMATPwas used. The
rest of the protocol was followed according to manufacturer’s instructions (Innova Biosciences Ltd). For the R2-TTT ATPase assay,
0.25 mMRUVBL1-RUVBL2 and 0.75 mMTTT complexes weremixed with abovementioned buffer and the PiColorLock reagents. The
reaction mixture was incubated at 37C for 30mins. For the negative control, 400 mMATP alone and/or proteins alone were used. The
reactions were scanned at 650nm using CLARIOstar (Biomedical Solutions Inc.) .
TOR kinase assay
To measure the effect of TTT and R2TP in mTOR kinase activity, we used 1 mM KmTOR-Lst8 1 mM, 3 mM Rvb1p/2p (hexamer) and
5.5 mM ScTel2-TTi1-TTi2, and 16 mM purified 4EBP1 protein. The kinase assay was performed using HEPES buffer (25mM HEPES,
pH 7.5, 50mMKCl, 5mMMnCl2, 5mMMgCl2 in a final volume of 20 ml. The kinase reaction was conducted in the presence of 100 mM
ATP at 23C for 30mins. For the negative control experiment, we used 10 mMATP competitivemTOR kinase inhibitor Dactolisib (com-
pany). The reaction was stopped by the addition of 20mM EDTA followed by the addition of 5 mL Laemmli buffer followed by imme-
diate boiling for 5mins at 100C. The samples were subjected to standard western blot using 4%–12% SDS-PAGE. The phosphor-
ylated 4EBP1 was detected by using anti-Phospho-4EBP1 (Thr37/46) polyclonal antibody (Cell Signaling Technology, cat. number
236B4). Chemiluminescence reaction was visualized using ECL solution (GE Healthcare) according to the manufacturer’s
instructions.
Reconstitution of R2TP-TTT and R2-TTT complexes
1 mM of the human and yeast R2TP/RUVBL1-RUVBL2 complexes was assembled according to previously described method (Mar-
tino et al., 2018; Rivera-Calzada et al., 2017). 2 mM of pure yeast and human TTT complex were mixed with R2TP/RUVBL1-RUVBL2
complexes and these assembled complexes were incubated for 1 hour at 4C. The quality of the samples was analyzed using 4%–
12% SDS-PAGE and ultimately used for the cryo-grids preparation.
Cryo-EM sample preparation and data collection
Freshly assembled preparations of the different complexes (1 mM)were used to prepare cryo-grids by applying 3.7 mL of complex to a
holey-carbon grids (QuantifoilTM 1.2/1.3, 300 mesh copper) which was glow discharged in air with PELCO easiGlow by applying a
current of 10mA for 60 s. Grids were blotted for 3 s at 25C and plunged into liquid ethane using FEI-Vitrobot Mark IV (Thermo Fisher
Scientific) or Leica EM GP2 (Leica microsystems) and stored in liquid nitrogen prior to imaging. Data were collected using FEI Titan
Krios electron microscopes at 300kV, equipped with a Gatan BioQuantum (slit width 20eV) K2 direct electron detectors operating in
countingmode. The R2-TTT andR2-T2 (TTi1-TTi2) data were collected at Astbury Biostructure Laboratory, Leeds, UK andR2TP-TTT
data was acquired at eBICDiamond Light Source, UK. Automated data acquisition software EPU (Thermo Fisher Scientific) was used
to collect data based on a published protocol (29) and with the parameters described in Table S1. Micrograph movies were collected
with 40 fractions across a 10 s exposure. Autofocusing was performed after every 10 mm. For R2-T2 and R2-TTT data was collected
using total doses of 49.6 e-/Å2 and 51.2 e-/Å2 respectively and the R2TP-TTT data was acquired with dose of 42.12 e/Å 2 over 40
fractions.
Cryo-EM data processing
All datasets (Table S1) were processed following similar strategies. Movies obtained for the different samples and imaging sessions
were aligned and local motions were corrected usingMotionCor2 (Zheng et al., 2017). The contrast transfer function (CTF) estimation
was performed using Gctf (Zhang, 2016). Particle selection, 2D and 3D classifications, refinement and all other image processing
steps were performed using the tools provided in Relion 2 (Kimanius et al., 2016) and Relion 3 (Zivanov et al., 2018), unless other
program is specified. Particles were automatically picked from the micrographs and bad particles from the initial datasets were
removed after several rounds of 2D classification and averaging. Cleaned datasets were then classified in several sub-groups in
3D using initial templates generated using the ab initio reconstruction tools in cryoSPARC (Punjani et al., 2017) and the ab-initio
routine available in Relion. The best sub-groups in each 3D classification were selected for refinement either separately or after merg-
ing those classes with similar features. The final structure was then selected and the particles were polished in Relion3.1 before a final
round of refinement using shiny particles. All final maps were post-processed and sharpened in Relion and the resolutions estimated
in Relion using gold standard Fourier Shell Correlation (FSC) and a cut-off of 0.5 and 0.143 as implemented in Relion. Local resolution
ranges for each map were estimated using Relion. Details about the initial and final number of images, estimated average resolution
and range of resolutions for each of the maps described in this work are indicated in Table S1.
To determine the structure of the R2-TTT complex, the sample was prepared by saturating R2 with an excess of TTT. We
collected two independent datasets in two sessions using the same microscope and imaging conditions which were initiallye4 Cell Reports 36, 109317, July 6, 2021
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OPEN ACCESSprocessed separately as detailed in Figure S1. Each dataset was cleaned by successive rounds of 2D and 3D classification to remove
bad particles. Remaining particles were then subjected to a round of 3D classification. Some of the 3D classes obtained were directly
removed after inspection of the volumes which were of poor quality, while the remaining sub-groups were subjected to image refine-
ment and we selected those classes that refined at higher resolution and where RUVBL1-RUVBL2 was occupied by 3 copies of TTT.
In the selected classes, several TTT complexes interacted with each RUVBL1-RUVBL2 hexamer and we implemented a symmetry
expansion strategy to make use of all the available information as described before (Martino et al., 2018; Zhou et al., 2015). Briefly,
because each R2-TTT complex has a roughly threefold symmetry and contained one, two or three TTT complexes per R2, we rotated
each particle around the 3-fold symmetry axis three times to place all TTT complexes in the same position. This operation triplicated
the dataset and then we placed a mask around one of the TTT positions and including part of the R2 ring. After symmetry expansion,
particles were classified and refined locally using a mask embracing the RUVBL1-RUVBL2 hexameric AAA+ core, the two DII do-
mains interacting with TTT and one copy of TTT. This allowed the reconstruction of the best classes, one for each dataset, at 4.3
and 3.4 Å resolution for dataset 1 and 2 respectively (Figure S2).
In order to improve the resolution of TTT, wemerged the particles that were part of the best volumes obtained from each dataset to
increase the number of good particles (Figure S1). In these maps, the resolution of the TTT complex was lower than the RUVBL1-
RUVBL2 hexamer and we therefore implemented a multi-body refinement strategy (Nakane et al., 2018). We defined two bodies,
corresponding to the TTT complex and the two DII domains in contact with TTT (body 1) and the RUVBL1-RUVBL2 hexamer except
the two DII domains in contact with TTT (body 2). Multi-body refinement revealed some flexibility in the interaction between TTT and
RUVBL1-RUVBL2 and significantly improved the resolution of the density corresponding to TTT. Particles were subjected first to a
local classification strategy using a mask including only the density for TTT to select those particles of the best quality and more ho-
mogeneous TTT complexes, which were then refined using themulti-body strategy. The resolution of the TTT body was estimated as
5.0 Å using an FSC cut-off of 0.143 (Figure S2). We explored if dividing the TTT body in several smaller sub-bodies could improve
resolution, but this attempt proved for most part unsuccessful, with the exception of the region assigned to TELON-terminal domain.
A final composite mapwas built using the best RUVBL1-RUVBL2 hexameric core corresponding to the single-body refinement of R2-
TTT from dataset 2, the best TTT obtained from the merged particles, and the body corresponding to TELO2 N-terminal domain.
To prepare the human R2TP-TTT for cryo-EM analysis, we mixed RUVBL1-RUVBL2 with an excess of RPAP3-PIH1D1 complex
using conditions that have been shown before to saturate RUVBL1-RUVBL2 and generate a sample where most R2 is forming
R2TP complexes (Martino et al., 2018; Maurizy et al., 2018; Munoz-Hernandez et al., 2019). Images were collected and particles pro-
cessed using similar methodologies to those described above (Figure S6). Although we could potentially expect detecting images of
R2, R2TP, R2-TTT and R2TP-TTT in the micrographs, because we used an excess of RPAP3-PIH1D1 and TTT with respect to
RUVBL1-RUVBL2 in the reaction, the mix should be substantially enriched in R2TP-TTT. Accordingly, 2D averages obtained from
the images in this experiment only found R2TP-TTT. R2TP could be readily distinguished from RUVBL1-RUVBL2 in the 2D averages
by the presence of the C-terminal domain of RPAP3 interacting at the ATPase-face of the RUVBL1-RUVBL2 ring, and TTT was visible
as a density attached at the DII face of the ring (Figure S6). 3D classifications also confirmed that all the classes containing good
particles corresponded to R2TP-TTT.
Model generation, fitting, and visualization
Atomicmodels for human RUVBL1 and RUVBL2 and RPAP3-RBD, were derived from previous cryoEM and NMR structures (Martino
et al., 2018; Maurizy et al., 2018; Munoz-Hernandez et al., 2019) and initially docked as rigid bodies into cryoEM density in Chimera
(Goddard et al., 2007). Homology models of the DII domains, which were not fully resolved in previous structures were constructed
using I-TASSER (Roy et al., 2010), merged into the experimentally determined RUVBL1 and RUVBL2 models, docked into density
using Chimera, and geometrically regularised in Coot (Casanal et al., 2020). A homologymodel for human TELO2N-domain was con-
structed using the I-TASSER server. Side-chains were stripped back to Cb except for proline residues, and the model docked as a
rigid body into density using Chimera. The position and orientation of individual helices, and their connecting loops was manually
optimized to the experimental density in Coot. Models for TTI1 and TTI2 were constructed by manual building of poly-alanine a he-
lices into experimental density, using the right-handed solenoid topology of HEAT repeat to determine connections. The polarity of
the two chains was subsequently determined by biochemical analyses and the models adjusted accordingly. Based on the length of
these proteins, the current TTI1 and TTI2 HEAT-repeat models account for 60% and 90% of the amino acid sequences of these
proteins, respectively. The fit of the overall model was optimized by real-space refinement in Phenix (Afonine et al., 2018) to a com-
bined map generated from a consensus of the highest resolution overall map, and individual local-resolution filtered multibody-
refined volumes (see above). All structural depictions were generated using Chimera.
Cross-linking mass spectrometry (XL-MS) of the human R2TP-TTT complex
The 1uM assembled complex of R2TP-TTT (in 20 mM HEPES pH 8.0, 140mM NaCl, 0.5mM TCEP) was cross-linked with a 100-fold
excess of isotopically labeled N-hydroxysuccinimide (NHS) ester disuccinimidyl suberate (DSS-H12/D12, Creative Molecules Inc.,
Canada), with respect to the protein concentration. The cross-linking reactions were incubated for 60 minutes at room temperature
and then quenched by the addition of NH4HCO3 to a final concentration of 20 mM and incubated for further 15 min.
The cross-linked proteins were reduced with 10 mM DTT and alkylated with 50 mM iodoacetamide. Following alkylation, the pro-
teins were digested with trypsin (Promega, UK) at an enzyme-to-substrate ratio of 1:50 in an overnight incubation at 37C followed byCell Reports 36, 109317, July 6, 2021 e5
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OPEN ACCESSthe addition of Glu-C protease (Promega, UK) at a ratio of 1:10 and incubated for 4 hours at 37C. After digestion, the samples
were acidified with formic acid to a final concentration of 2% v/v and the peptides fractionated by peptide size exclusion chroma-
tography, using a Superdex Peptide 3.2/300 (GE Healthcare) with 30% v/v Acetonitrile/0.1% v/v TFA as mobile phase and at a
flow rate of 50 ml/min. Fractions were collected every 2 min over the elution volume 1.0 mL to 1.7 ml. Prior to LC-MS/MS analysis
fractions were freeze-dried.
Lyophilized peptides for LC-MS/MS were resuspended in 0.1% (v/v) formic acid and 2% (v/v) acetonitrile and analyzed by nano-
scale capillary LC-MS/MS using an Ultimate U3000 HPLC (ThermoScientific Dionex, USA) to deliver a flow of approximately 300 nl/
min. A C18 Acclaim PepMap100 5 mm, 100 mm 3 20 mm nanoViper (ThermoScientific Dionex, USA), trapped the peptides before
separation on a C18 Acclaim PepMap100 3 mm, 75 mm3 250 mm nanoViper (ThermoScientific Dionex, USA). Peptides were eluted
with a gradient of acetonitrile. The analytical column outlet was directly interfaced via a nano-flow electrospray ionisation source, with
a hybrid dual pressure linear ion trapmass spectrometer (Orbitrap Velos, ThermoScientific, San Jose, USA). Data dependent analysis
was carried out, using a resolution of 30,000 for the full MS spectrum, followed by ten MS/MS spectra in the linear ion trap. MS
spectra were collected over a m/z range of 300–2000. MS/MS scans were collected using threshold energy of 35 for collision-
induced dissociation.
For data analysis, Xcalibur raw files were converted into the MGF format through MSConvert (Proteowizard; (Kessner et al., 2008))
and used directly as input files for StavroX (Götze et al., 2015). Searches were performed against an ad hoc protein database con-
taining the sequences of the complex and a set of randomized decoy sequences generated by the software. The following param-
eters were set for the searches: maximum number of missed cleavages 3; targeted residues K, S, Y and T; minimum peptide length 5
amino acids; variable modifications: carbamidomethyl-Cys (mass shift 57.02146 Da), Met-oxidation (mass shift 15.99491 Da); DSS
cross-links mass shift 138.06808 Da (precision: 10 ppmMS1 and 0.8 Da MS2); False Discovery Rate cut-off: 5%. Finally, each frag-
mentation spectrum was manually inspected and validated.
QUANTITATION AND STATISTICAL ANALYSIS
Data were fitted to the Michaelis–Menten equation using non-linear regression in GraphPad Prism Software 8 to calculate the
reported Vmax and Km values.e6 Cell Reports 36, 109317, July 6, 2021
